Market Outlook
The global OTC Anti-Infective Products market size was valued at USD 13710 million in 2022 and is forecast to a readjusted size of USD 17150 million by 2029 with a CAGR of 3.3% during review period.
Anti-infectives are medicines that work to prevent or treat infections.
Anti-infective drugs used for the purpose of killing or suppressing the infection causing organisms from invading the host by means of its replication or releasing variety of toxins into the host. Infection causing micro-organisms include bacteria, viruses, fungi, viroids, and macro parasites.
Global core OTC anti-infective products manufacturers include Teva, MYLAN and NOVARTIS etc. The Top 3 companies hold a share above 10%. Asia-Pacific is the largest market, with a share about 38%, followed by North America and Europe with the share about 30% and 20%.
This report is a detailed and comprehensive analysis for global OTC Anti-Infective Products market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Sales Channel. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global OTC Anti-Infective Products market size and forecasts, in consumption value ($ Million), sales quantity (M Units), and average selling prices (US$/Unit), 2018-2029
Global OTC Anti-Infective Products market size and forecasts by region and country, in consumption value ($ Million), sales quantity (M Units), and average selling prices (US$/Unit), 2018-2029
Global OTC Anti-Infective Products market size and forecasts, by Type and by Sales Channel, in consumption value ($ Million), sales quantity (M Units), and average selling prices (US$/Unit), 2018-2029
Global OTC Anti-Infective Products market shares of main players, shipments in revenue ($ Million), sales quantity (M Units), and ASP (US$/Unit), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for OTC Anti-Infective Products
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global OTC Anti-Infective Products market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Key Market Players
Bayer
GSK
Teva
Johnson & Johnson
NOVARTIS
MYLAN
Sun Pharma
CR SANJIU
Cipla
Lingrui
Segmentation By Type
Antifungal
Antibacterial
Antiviral
Antiseptics
Others
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Segmentation By Region
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
Market SWOT Analysis
What are the strengths of the OTC Anti-Infective Products Market in 2025?
The market benefits from high consumer demand driven by increased awareness of health and self-care. Accessibility, convenience, and affordability are key strengths, allowing consumers to easily access anti-infective treatments without a prescription. Additionally, advancements in product formulations and better distribution channels are further expanding the market.
What are the weaknesses of the OTC Anti-Infective Products Market in 2025?
A potential weakness lies in the risk of misuse or overuse of OTC anti-infective products, which can lead to antimicrobial resistance. There is also a challenge in educating consumers about appropriate use to prevent self-diagnosis errors. Furthermore, the lack of a one-size-fits-all solution for various infections may limit product effectiveness.
What are the opportunities for growth in the OTC Anti-Infective Products Market in 2025?
With the increasing prevalence of infections and rising healthcare costs, there is a growing opportunity to expand the market for OTC anti-infective products. Additionally, the growing trend of personalized healthcare and innovations in product formulations, such as natural and organic anti-infectives, create opportunities for new product lines and targeted marketing strategies.
What are the threats facing the OTC Anti-Infective Products Market in 2025?
The market faces regulatory scrutiny and potential restrictions on OTC anti-infective sales, as health authorities may tighten regulations due to misuse concerns. Competition from prescription-based alternatives and the development of new pharmaceutical products could also pose a threat. Additionally, the growing trend of consumers seeking holistic or alternative treatments might limit the market’s potential growth.
Market PESTEL Analysis
What are the political factors influencing the OTC Anti-Infective Products Market in 2025?
Government regulations on the sale of OTC anti-infective products are a significant political factor. Authorities may enforce stricter laws to prevent misuse and over-the-counter sales of products that could contribute to antimicrobial resistance. Policies promoting self-care and preventative health measures could also boost the market.
How do economic factors impact the OTC Anti-Infective Products Market in 2025?
Economic factors, such as rising healthcare costs, drive consumers toward affordable OTC anti-infective products as alternatives to prescription drugs. Economic downturns might lead to higher demand for cost-effective self-treatment options, while rising disposable income could result in greater spending on healthcare and wellness products.
What social factors are affecting the OTC Anti-Infective Products Market in 2025?
An increasing trend toward self-care and health-consciousness among consumers is driving the OTC anti-infective market. People are becoming more proactive about their health and prefer easily accessible solutions. However, social misconceptions and the lack of proper education regarding correct usage could affect the market's growth and effectiveness.
How does technology influence the OTC Anti-Infective Products Market in 2025?
Advancements in technology have led to the development of more effective and user-friendly OTC anti-infective products. E-commerce platforms have expanded access, making these products more convenient to purchase. Additionally, innovations in product formulations, such as natural or combination therapies, are likely to attract more consumers.
What environmental factors are affecting the OTC Anti-Infective Products Market in 2025?
Environmental awareness may lead to increased demand for eco-friendly packaging and sustainably sourced ingredients in OTC anti-infective products. There is also a growing concern regarding the environmental impact of pharmaceuticals, which could drive market shifts toward greener, more sustainable options.
What legal factors are impacting the OTC Anti-Infective Products Market in 2025?
Tighter regulations surrounding the sale and marketing of OTC anti-infective products could limit market access and affect the types of products allowed for public sale. Legal restrictions on certain ingredients or formulations to prevent misuse or resistance could also influence the development and distribution of new products.
Market SIPOC Analysis
Who are the suppliers in the OTC Anti-Infective Products Market in 2025?
Suppliers include pharmaceutical companies, raw material providers, packaging manufacturers, and ingredient suppliers, such as those producing active ingredients, excipients, and natural components. Additionally, suppliers of research and development services and regulatory consultation are vital to ensuring compliance and effective product development.
What are the inputs in the OTC Anti-Infective Products Market in 2025?
Inputs consist of raw materials like active pharmaceutical ingredients (APIs), preservatives, and packaging materials. Additionally, research data, consumer insights, and market trends are key inputs. Regulatory guidelines, manufacturing technology, and distribution channels also play a role in delivering the final product.
What processes occur in the OTC Anti-Infective Products Market in 2025?
The processes include product development, clinical testing, regulatory approval, manufacturing, packaging, and distribution. Once products are ready, marketing and sales teams promote them through both physical retail and online platforms. Consumer education on proper use is also a key process in reducing misuse and ensuring safety.
Who are the customers in the OTC Anti-Infective Products Market in 2025?
Customers include individual consumers seeking over-the-counter treatments for infections, healthcare providers recommending self-care solutions, and retail chains or online pharmacies distributing the products. The market is also shaped by health-conscious individuals and those looking for affordable, convenient treatment options.
What are the outputs of the OTC Anti-Infective Products Market in 2025?
The outputs are the OTC anti-infective products themselves, such as creams, ointments, sprays, and oral medications designed to treat infections. These products aim to provide effective, easily accessible treatments for consumers. Marketing materials, product education, and regulatory compliance reports are also important outputs in ensuring successful market penetration.
Market Porter's Five Forces
How intense is the threat of new entrants in the OTC Anti-Infective Products Market in 2025?
The threat of new entrants is moderate. While the market offers significant opportunities due to growing consumer demand, high regulatory barriers, brand loyalty, and the need for significant investment in R&D and distribution create challenges for new players. Established companies already dominate, making it harder for new entrants to gain a foothold.
What is the bargaining power of suppliers in the OTC Anti-Infective Products Market in 2025?
The bargaining power of suppliers is moderate. Key suppliers of active ingredients and raw materials hold some power, especially if they provide unique or patented compounds. However, the wide availability of alternative suppliers for many ingredients and the ability to source from multiple regions reduces supplier power.
How strong is the bargaining power of buyers in the OTC Anti-Infective Products Market in 2025?
The bargaining power of buyers is high. With many OTC anti-infective products available, consumers can easily switch brands based on price, effectiveness, or product form. Increased awareness and easy access to information empower consumers to make informed choices, heightening their bargaining power.
What is the threat of substitute products in the OTC Anti-Infective Products Market in 2025?
The threat of substitutes is moderate to high. Natural remedies, homeopathic treatments, and other alternative medicine options can serve as substitutes for OTC anti-infective products. Additionally, prescription medications or advanced treatments could provide more effective alternatives, especially for more serious infections.
How intense is the rivalry among existing competitors in the OTC Anti-Infective Products Market in 2025?
Rivalry among existing competitors is high. The OTC anti-infective market is fragmented with many players vying for market share. Competitive pressures are driven by price, brand reputation, product differentiation, and marketing efforts. Established companies, as well as smaller, innovative brands, compete to capture consumer attention and loyalty.
Market Upstream Analysis
What are the key suppliers in the OTC Anti-Infective Products Market in 2025?
Key suppliers include pharmaceutical manufacturers of active pharmaceutical ingredients (APIs), raw material providers for excipients and preservatives, packaging suppliers, and companies specializing in research and development for new formulations. Suppliers of regulatory services and market research also play a role in ensuring compliance and identifying consumer trends.
How do raw material costs impact the OTC Anti-Infective Products Market in 2025?
Rising raw material costs can increase the production expenses of OTC anti-infective products, which may result in higher prices for consumers. Variability in the cost of active ingredients, such as antibiotics or herbal compounds, directly influences pricing and profit margins, potentially limiting affordability for some consumers.
What role does research and development play in the upstream dynamics of the OTC Anti-Infective Products Market in 2025?
R&D is crucial in driving innovation, particularly in formulating new and effective OTC anti-infective products. Advances in R&D allow companies to introduce safer, more efficient, or natural alternatives to existing treatments, helping brands differentiate in a competitive market. Research into antimicrobial resistance and consumer preferences shapes product development strategies.
How do regulations affect the upstream activities in the OTC Anti-Infective Products Market in 2025?
Regulations impact upstream activities by determining which ingredients are approved for use, the manufacturing processes required, and the overall safety and efficacy standards. Stricter regulations could increase production costs, as companies must invest in compliance, clinical trials, and certification processes. These regulations ensure the quality of products but may limit innovation or increase time-to-market.
What is the impact of supplier relationships on the OTC Anti-Infective Products Market in 2025?
Strong supplier relationships are essential for securing high-quality raw materials, ensuring consistent supply, and managing costs. Long-term relationships with key suppliers of active ingredients, packaging, and research services allow manufacturers to maintain product quality, reduce lead times, and manage costs effectively, which are critical for staying competitive in the market.
Market Midstream Analysis
What are the key processes in the midstream of the OTC Anti-Infective Products Market in 2025?
Key processes include manufacturing, quality control, packaging, and distribution. After raw materials are sourced, products undergo manufacturing where active ingredients are combined, tested for safety and efficacy, and packaged for retail. Distribution channels, including wholesalers, pharmacies, and online platforms, then ensure products reach consumers efficiently.
How does the supply chain affect the OTC Anti-Infective Products Market in 2025?
The supply chain plays a critical role in ensuring product availability, consistency, and timely delivery to consumers. Any disruptions in the supply of raw materials or distribution networks can lead to shortages, delays, or increased costs. Efficient supply chains help control costs, ensuring products remain competitively priced while maintaining availability.
What role do distributors play in the OTC Anti-Infective Products Market in 2025?
Distributors bridge the gap between manufacturers and end consumers, ensuring the efficient flow of products across retail channels. They manage inventory, logistics, and sometimes marketing efforts. Distributors must also stay informed about regulatory changes and market trends to adapt product offerings and meet consumer demand effectively.
How do regulatory requirements impact the midstream activities in the OTC Anti-Infective Products Market in 2025?
Regulatory requirements ensure that all products meet safety and efficacy standards, affecting manufacturing processes and distribution. Compliance with these regulations is critical for companies to avoid penalties and product recalls. These standards also influence packaging, labeling, and product claims, which must be aligned with regulatory guidelines to be marketable.
What impact does technological advancement have on the midstream in the OTC Anti-Infective Products Market in 2025?
Technological advancements improve the efficiency and quality of manufacturing processes, such as automation in production lines and improved testing methods. Additionally, advancements in logistics and supply chain management technology streamline distribution and inventory tracking, reducing costs and improving speed to market. Technology also supports product traceability, which enhances consumer trust and safety.
Market Downstream Analysis
What are the key downstream activities in the OTC Anti-Infective Products Market in 2025?
Key downstream activities include retail sales, marketing, and consumer education. After products are distributed to retailers or online platforms, marketing efforts are crucial to drive consumer awareness and sales. Consumer education also plays a vital role in ensuring the safe and effective use of OTC anti-infective products.
How does consumer behavior influence the OTC Anti-Infective Products Market in 2025?
Consumer behavior is significantly influenced by factors like convenience, price sensitivity, and increasing health awareness. With the rise of online shopping, consumers expect easy access to OTC anti-infective products. Additionally, the trend toward natural or alternative treatments influences purchasing decisions, with consumers actively seeking products that align with their preferences.
What role does retail play in the OTC Anti-Infective Products Market in 2025?
Retail, both physical and online, is essential for reaching the end consumer. Retailers act as the main touchpoint for OTC anti-infective products, with pharmacies, drugstores, and e-commerce platforms driving product availability and sales. In-store promotions and online marketing are key strategies for product visibility and consumer engagement.
How do marketing and advertising affect the OTC Anti-Infective Products Market in 2025?
Effective marketing and advertising strategies are essential for creating brand awareness and educating consumers about the benefits and proper use of OTC anti-infective products. Promotional campaigns, social media presence, and influencer partnerships are increasingly important in reaching a broad audience, especially younger, health-conscious consumers.
What challenges do companies face in the downstream sector of the OTC Anti-Infective Products Market in 2025?
Companies face challenges like intense competition, pricing pressures, and the need to meet regulatory standards in advertising and labeling. Additionally, convincing consumers of the safety and efficacy of OTC products amid rising concerns over antimicrobial resistance is a key hurdle. Consumer skepticism about self-diagnosing and using over-the-counter treatments also poses a challenge.
Chapter 1, to describe OTC Anti-Infective Products product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of OTC Anti-Infective Products, with price, sales, revenue and global market share of OTC Anti-Infective Products from 2018 to 2023.
Chapter 3, the OTC Anti-Infective Products competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the OTC Anti-Infective Products breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2018 to 2029.
Chapter 5 and 6, to segment the sales by Type and sales channel, with sales market share and growth rate by type, sales channel, from 2018 to 2029.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2022.and OTC Anti-Infective Products market forecast, by regions, type and sales channel, with sales and revenue, from 2024 to 2029.
Chapter 12, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War.
Chapter 13, the key raw materials and key suppliers, and industry chain of OTC Anti-Infective Products.
Chapter 14 and 15, to describe OTC Anti-Infective Products sales channel, distributors, customers, research findings and conclusion.
1 Market Overview
1.1 Product Overview and Scope of OTC Anti-Infective Products
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global OTC Anti-Infective Products Consumption Value by Type: 2018 Versus 2022 Versus 2029
1.3.2 Antifungal
1.3.3 Antibacterial
1.3.4 Antiviral
1.3.5 Antiseptics
1.3.6 Others
1.4 Market Analysis by Sales Channel
1.4.1 Overview: Global OTC Anti-Infective Products Consumption Value by Sales Channel: 2018 Versus 2022 Versus 2029
1.4.2 Hospital Pharmacies
1.4.3 Retail Pharmacies
1.4.4 Online Pharmacies
1.5 Global OTC Anti-Infective Products Market Size & Forecast
1.5.1 Global OTC Anti-Infective Products Consumption Value (2018 & 2022 & 2029)
1.5.2 Global OTC Anti-Infective Products Sales Quantity (2018-2029)
1.5.3 Global OTC Anti-Infective Products Average Price (2018-2029)
2 Manufacturers Profiles
2.1 Bayer
2.1.1 Bayer Details
2.1.2 Bayer Major Business
2.1.3 Bayer OTC Anti-Infective Products Product and Services
2.1.4 Bayer OTC Anti-Infective Products Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 Bayer Recent Developments/Updates
2.2 GSK
2.2.1 GSK Details
2.2.2 GSK Major Business
2.2.3 GSK OTC Anti-Infective Products Product and Services
2.2.4 GSK OTC Anti-Infective Products Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 GSK Recent Developments/Updates
2.3 Teva
2.3.1 Teva Details
2.3.2 Teva Major Business
2.3.3 Teva OTC Anti-Infective Products Product and Services
2.3.4 Teva OTC Anti-Infective Products Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 Teva Recent Developments/Updates
2.4 Johnson & Johnson
2.4.1 Johnson & Johnson Details
2.4.2 Johnson & Johnson Major Business
2.4.3 Johnson & Johnson OTC Anti-Infective Products Product and Services
2.4.4 Johnson & Johnson OTC Anti-Infective Products Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 Johnson & Johnson Recent Developments/Updates
2.5 NOVARTIS
2.5.1 NOVARTIS Details
2.5.2 NOVARTIS Major Business
2.5.3 NOVARTIS OTC Anti-Infective Products Product and Services
2.5.4 NOVARTIS OTC Anti-Infective Products Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 NOVARTIS Recent Developments/Updates
2.6 MYLAN
2.6.1 MYLAN Details
2.6.2 MYLAN Major Business
2.6.3 MYLAN OTC Anti-Infective Products Product and Services
2.6.4 MYLAN OTC Anti-Infective Products Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 MYLAN Recent Developments/Updates
2.7 Sun Pharma
2.7.1 Sun Pharma Details
2.7.2 Sun Pharma Major Business
2.7.3 Sun Pharma OTC Anti-Infective Products Product and Services
2.7.4 Sun Pharma OTC Anti-Infective Products Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 Sun Pharma Recent Developments/Updates
2.8 CR SANJIU
2.8.1 CR SANJIU Details
2.8.2 CR SANJIU Major Business
2.8.3 CR SANJIU OTC Anti-Infective Products Product and Services
2.8.4 CR SANJIU OTC Anti-Infective Products Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 CR SANJIU Recent Developments/Updates
2.9 Cipla
2.9.1 Cipla Details
2.9.2 Cipla Major Business
2.9.3 Cipla OTC Anti-Infective Products Product and Services
2.9.4 Cipla OTC Anti-Infective Products Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.9.5 Cipla Recent Developments/Updates
2.10 Lingrui
2.10.1 Lingrui Details
2.10.2 Lingrui Major Business
2.10.3 Lingrui OTC Anti-Infective Products Product and Services
2.10.4 Lingrui OTC Anti-Infective Products Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.10.5 Lingrui Recent Developments/Updates
3 Competitive Environment: OTC Anti-Infective Products by Manufacturer
3.1 Global OTC Anti-Infective Products Sales Quantity by Manufacturer (2018-2023)
3.2 Global OTC Anti-Infective Products Revenue by Manufacturer (2018-2023)
3.3 Global OTC Anti-Infective Products Average Price by Manufacturer (2018-2023)
3.4 Market Share Analysis (2022)
3.4.1 Producer Shipments of OTC Anti-Infective Products by Manufacturer Revenue ($MM) and Market Share (%): 2022
3.4.2 Top 3 OTC Anti-Infective Products Manufacturer Market Share in 2022
3.4.2 Top 6 OTC Anti-Infective Products Manufacturer Market Share in 2022
3.5 OTC Anti-Infective Products Market: Overall Company Footprint Analysis
3.5.1 OTC Anti-Infective Products Market: Region Footprint
3.5.2 OTC Anti-Infective Products Market: Company Product Type Footprint
3.5.3 OTC Anti-Infective Products Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 Consumption Analysis by Region
4.1 Global OTC Anti-Infective Products Market Size by Region
4.1.1 Global OTC Anti-Infective Products Sales Quantity by Region (2018-2029)
4.1.2 Global OTC Anti-Infective Products Consumption Value by Region (2018-2029)
4.1.3 Global OTC Anti-Infective Products Average Price by Region (2018-2029)
4.2 North America OTC Anti-Infective Products Consumption Value (2018-2029)
4.3 Europe OTC Anti-Infective Products Consumption Value (2018-2029)
4.4 Asia-Pacific OTC Anti-Infective Products Consumption Value (2018-2029)
4.5 South America OTC Anti-Infective Products Consumption Value (2018-2029)
4.6 Middle East and Africa OTC Anti-Infective Products Consumption Value (2018-2029)
5 Market Segment by Type
5.1 Global OTC Anti-Infective Products Sales Quantity by Type (2018-2029)
5.2 Global OTC Anti-Infective Products Consumption Value by Type (2018-2029)
5.3 Global OTC Anti-Infective Products Average Price by Type (2018-2029)
6 Market Segment by Sales Channel
6.1 Global OTC Anti-Infective Products Sales Quantity by Sales Channel (2018-2029)
6.2 Global OTC Anti-Infective Products Consumption Value by Sales Channel (2018-2029)
6.3 Global OTC Anti-Infective Products Average Price by Sales Channel (2018-2029)
7 North America
7.1 North America OTC Anti-Infective Products Sales Quantity by Type (2018-2029)
7.2 North America OTC Anti-Infective Products Sales Quantity by Sales Channel (2018-2029)
7.3 North America OTC Anti-Infective Products Market Size by Country
7.3.1 North America OTC Anti-Infective Products Sales Quantity by Country (2018-2029)
7.3.2 North America OTC Anti-Infective Products Consumption Value by Country (2018-2029)
7.3.3 United States Market Size and Forecast (2018-2029)
7.3.4 Canada Market Size and Forecast (2018-2029)
7.3.5 Mexico Market Size and Forecast (2018-2029)
8 Europe
8.1 Europe OTC Anti-Infective Products Sales Quantity by Type (2018-2029)
8.2 Europe OTC Anti-Infective Products Sales Quantity by Sales Channel (2018-2029)
8.3 Europe OTC Anti-Infective Products Market Size by Country
8.3.1 Europe OTC Anti-Infective Products Sales Quantity by Country (2018-2029)
8.3.2 Europe OTC Anti-Infective Products Consumption Value by Country (2018-2029)
8.3.3 Germany Market Size and Forecast (2018-2029)
8.3.4 France Market Size and Forecast (2018-2029)
8.3.5 United Kingdom Market Size and Forecast (2018-2029)
8.3.6 Russia Market Size and Forecast (2018-2029)
8.3.7 Italy Market Size and Forecast (2018-2029)
9 Asia-Pacific
9.1 Asia-Pacific OTC Anti-Infective Products Sales Quantity by Type (2018-2029)
9.2 Asia-Pacific OTC Anti-Infective Products Sales Quantity by Sales Channel (2018-2029)
9.3 Asia-Pacific OTC Anti-Infective Products Market Size by Region
9.3.1 Asia-Pacific OTC Anti-Infective Products Sales Quantity by Region (2018-2029)
9.3.2 Asia-Pacific OTC Anti-Infective Products Consumption Value by Region (2018-2029)
9.3.3 China Market Size and Forecast (2018-2029)
9.3.4 Japan Market Size and Forecast (2018-2029)
9.3.5 Korea Market Size and Forecast (2018-2029)
9.3.6 India Market Size and Forecast (2018-2029)
9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
9.3.8 Australia Market Size and Forecast (2018-2029)
10 South America
10.1 South America OTC Anti-Infective Products Sales Quantity by Type (2018-2029)
10.2 South America OTC Anti-Infective Products Sales Quantity by Sales Channel (2018-2029)
10.3 South America OTC Anti-Infective Products Market Size by Country
10.3.1 South America OTC Anti-Infective Products Sales Quantity by Country (2018-2029)
10.3.2 South America OTC Anti-Infective Products Consumption Value by Country (2018-2029)
10.3.3 Brazil Market Size and Forecast (2018-2029)
10.3.4 Argentina Market Size and Forecast (2018-2029)
11 Middle East & Africa
11.1 Middle East & Africa OTC Anti-Infective Products Sales Quantity by Type (2018-2029)
11.2 Middle East & Africa OTC Anti-Infective Products Sales Quantity by Sales Channel (2018-2029)
11.3 Middle East & Africa OTC Anti-Infective Products Market Size by Country
11.3.1 Middle East & Africa OTC Anti-Infective Products Sales Quantity by Country (2018-2029)
11.3.2 Middle East & Africa OTC Anti-Infective Products Consumption Value by Country (2018-2029)
11.3.3 Turkey Market Size and Forecast (2018-2029)
11.3.4 Egypt Market Size and Forecast (2018-2029)
11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
11.3.6 South Africa Market Size and Forecast (2018-2029)
12 Market Dynamics
12.1 OTC Anti-Infective Products Market Drivers
12.2 OTC Anti-Infective Products Market Restraints
12.3 OTC Anti-Infective Products Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
12.5 Influence of COVID-19 and Russia-Ukraine War
12.5.1 Influence of COVID-19
12.5.2 Influence of Russia-Ukraine War
13 Raw Material and Industry Chain
13.1 Raw Material of OTC Anti-Infective Products and Key Manufacturers
13.2 Manufacturing Costs Percentage of OTC Anti-Infective Products
13.3 OTC Anti-Infective Products Production Process
13.4 OTC Anti-Infective Products Industrial Chain
14 Shipments by Distribution Channel
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 OTC Anti-Infective Products Typical Distributors
14.3 OTC Anti-Infective Products Typical Customers
15 Research Findings and Conclusion
16 Appendix
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
List of Tables
Table 1. Global OTC Anti-Infective Products Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global OTC Anti-Infective Products Consumption Value by Sales Channel, (USD Million), 2018 & 2022 & 2029
Table 3. Bayer Basic Information, Manufacturing Base and Competitors
Table 4. Bayer Major Business
Table 5. Bayer OTC Anti-Infective Products Product and Services
Table 6. Bayer OTC Anti-Infective Products Sales Quantity (M Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 7. Bayer Recent Developments/Updates
Table 8. GSK Basic Information, Manufacturing Base and Competitors
Table 9. GSK Major Business
Table 10. GSK OTC Anti-Infective Products Product and Services
Table 11. GSK OTC Anti-Infective Products Sales Quantity (M Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 12. GSK Recent Developments/Updates
Table 13. Teva Basic Information, Manufacturing Base and Competitors
Table 14. Teva Major Business
Table 15. Teva OTC Anti-Infective Products Product and Services
Table 16. Teva OTC Anti-Infective Products Sales Quantity (M Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 17. Teva Recent Developments/Updates
Table 18. Johnson & Johnson Basic Information, Manufacturing Base and Competitors
Table 19. Johnson & Johnson Major Business
Table 20. Johnson & Johnson OTC Anti-Infective Products Product and Services
Table 21. Johnson & Johnson OTC Anti-Infective Products Sales Quantity (M Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 22. Johnson & Johnson Recent Developments/Updates
Table 23. NOVARTIS Basic Information, Manufacturing Base and Competitors
Table 24. NOVARTIS Major Business
Table 25. NOVARTIS OTC Anti-Infective Products Product and Services
Table 26. NOVARTIS OTC Anti-Infective Products Sales Quantity (M Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 27. NOVARTIS Recent Developments/Updates
Table 28. MYLAN Basic Information, Manufacturing Base and Competitors
Table 29. MYLAN Major Business
Table 30. MYLAN OTC Anti-Infective Products Product and Services
Table 31. MYLAN OTC Anti-Infective Products Sales Quantity (M Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 32. MYLAN Recent Developments/Updates
Table 33. Sun Pharma Basic Information, Manufacturing Base and Competitors
Table 34. Sun Pharma Major Business
Table 35. Sun Pharma OTC Anti-Infective Products Product and Services
Table 36. Sun Pharma OTC Anti-Infective Products Sales Quantity (M Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 37. Sun Pharma Recent Developments/Updates
Table 38. CR SANJIU Basic Information, Manufacturing Base and Competitors
Table 39. CR SANJIU Major Business
Table 40. CR SANJIU OTC Anti-Infective Products Product and Services
Table 41. CR SANJIU OTC Anti-Infective Products Sales Quantity (M Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 42. CR SANJIU Recent Developments/Updates
Table 43. Cipla Basic Information, Manufacturing Base and Competitors
Table 44. Cipla Major Business
Table 45. Cipla OTC Anti-Infective Products Product and Services
Table 46. Cipla OTC Anti-Infective Products Sales Quantity (M Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 47. Cipla Recent Developments/Updates
Table 48. Lingrui Basic Information, Manufacturing Base and Competitors
Table 49. Lingrui Major Business
Table 50. Lingrui OTC Anti-Infective Products Product and Services
Table 51. Lingrui OTC Anti-Infective Products Sales Quantity (M Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 52. Lingrui Recent Developments/Updates
Table 53. Global OTC Anti-Infective Products Sales Quantity by Manufacturer (2018-2023) & (M Units)
Table 54. Global OTC Anti-Infective Products Revenue by Manufacturer (2018-2023) & (USD Million)
Table 55. Global OTC Anti-Infective Products Average Price by Manufacturer (2018-2023) & (US$/Unit)
Table 56. Market Position of Manufacturers in OTC Anti-Infective Products, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2022
Table 57. Head Office and OTC Anti-Infective Products Production Site of Key Manufacturer
Table 58. OTC Anti-Infective Products Market: Company Product Type Footprint
Table 59. OTC Anti-Infective Products Market: Company Product Application Footprint
Table 60. OTC Anti-Infective Products New Market Entrants and Barriers to Market Entry
Table 61. OTC Anti-Infective Products Mergers, Acquisition, Agreements, and Collaborations
Table 62. Global OTC Anti-Infective Products Sales Quantity by Region (2018-2023) & (M Units)
Table 63. Global OTC Anti-Infective Products Sales Quantity by Region (2024-2029) & (M Units)
Table 64. Global OTC Anti-Infective Products Consumption Value by Region (2018-2023) & (USD Million)
Table 65. Global OTC Anti-Infective Products Consumption Value by Region (2024-2029) & (USD Million)
Table 66. Global OTC Anti-Infective Products Average Price by Region (2018-2023) & (US$/Unit)
Table 67. Global OTC Anti-Infective Products Average Price by Region (2024-2029) & (US$/Unit)
Table 68. Global OTC Anti-Infective Products Sales Quantity by Type (2018-2023) & (M Units)
Table 69. Global OTC Anti-Infective Products Sales Quantity by Type (2024-2029) & (M Units)
Table 70. Global OTC Anti-Infective Products Consumption Value by Type (2018-2023) & (USD Million)
Table 71. Global OTC Anti-Infective Products Consumption Value by Type (2024-2029) & (USD Million)
Table 72. Global OTC Anti-Infective Products Average Price by Type (2018-2023) & (US$/Unit)
Table 73. Global OTC Anti-Infective Products Average Price by Type (2024-2029) & (US$/Unit)
Table 74. Global OTC Anti-Infective Products Sales Quantity by Sales Channel (2018-2023) & (M Units)
Table 75. Global OTC Anti-Infective Products Sales Quantity by Sales Channel (2024-2029) & (M Units)
Table 76. Global OTC Anti-Infective Products Consumption Value by Sales Channel (2018-2023) & (USD Million)
Table 77. Global OTC Anti-Infective Products Consumption Value by Sales Channel (2024-2029) & (USD Million)
Table 78. Global OTC Anti-Infective Products Average Price by Sales Channel (2018-2023) & (US$/Unit)
Table 79. Global OTC Anti-Infective Products Average Price by Sales Channel (2024-2029) & (US$/Unit)
Table 80. North America OTC Anti-Infective Products Sales Quantity by Type (2018-2023) & (M Units)
Table 81. North America OTC Anti-Infective Products Sales Quantity by Type (2024-2029) & (M Units)
Table 82. North America OTC Anti-Infective Products Sales Quantity by Sales Channel (2018-2023) & (M Units)
Table 83. North America OTC Anti-Infective Products Sales Quantity by Sales Channel (2024-2029) & (M Units)
Table 84. North America OTC Anti-Infective Products Sales Quantity by Country (2018-2023) & (M Units)
Table 85. North America OTC Anti-Infective Products Sales Quantity by Country (2024-2029) & (M Units)
Table 86. North America OTC Anti-Infective Products Consumption Value by Country (2018-2023) & (USD Million)
Table 87. North America OTC Anti-Infective Products Consumption Value by Country (2024-2029) & (USD Million)
Table 88. Europe OTC Anti-Infective Products Sales Quantity by Type (2018-2023) & (M Units)
Table 89. Europe OTC Anti-Infective Products Sales Quantity by Type (2024-2029) & (M Units)
Table 90. Europe OTC Anti-Infective Products Sales Quantity by Sales Channel (2018-2023) & (M Units)
Table 91. Europe OTC Anti-Infective Products Sales Quantity by Sales Channel (2024-2029) & (M Units)
Table 92. Europe OTC Anti-Infective Products Sales Quantity by Country (2018-2023) & (M Units)
Table 93. Europe OTC Anti-Infective Products Sales Quantity by Country (2024-2029) & (M Units)
Table 94. Europe OTC Anti-Infective Products Consumption Value by Country (2018-2023) & (USD Million)
Table 95. Europe OTC Anti-Infective Products Consumption Value by Country (2024-2029) & (USD Million)
Table 96. Asia-Pacific OTC Anti-Infective Products Sales Quantity by Type (2018-2023) & (M Units)
Table 97. Asia-Pacific OTC Anti-Infective Products Sales Quantity by Type (2024-2029) & (M Units)
Table 98. Asia-Pacific OTC Anti-Infective Products Sales Quantity by Sales Channel (2018-2023) & (M Units)
Table 99. Asia-Pacific OTC Anti-Infective Products Sales Quantity by Sales Channel (2024-2029) & (M Units)
Table 100. Asia-Pacific OTC Anti-Infective Products Sales Quantity by Region (2018-2023) & (M Units)
Table 101. Asia-Pacific OTC Anti-Infective Products Sales Quantity by Region (2024-2029) & (M Units)
Table 102. Asia-Pacific OTC Anti-Infective Products Consumption Value by Region (2018-2023) & (USD Million)
Table 103. Asia-Pacific OTC Anti-Infective Products Consumption Value by Region (2024-2029) & (USD Million)
Table 104. South America OTC Anti-Infective Products Sales Quantity by Type (2018-2023) & (M Units)
Table 105. South America OTC Anti-Infective Products Sales Quantity by Type (2024-2029) & (M Units)
Table 106. South America OTC Anti-Infective Products Sales Quantity by Sales Channel (2018-2023) & (M Units)
Table 107. South America OTC Anti-Infective Products Sales Quantity by Sales Channel (2024-2029) & (M Units)
Table 108. South America OTC Anti-Infective Products Sales Quantity by Country (2018-2023) & (M Units)
Table 109. South America OTC Anti-Infective Products Sales Quantity by Country (2024-2029) & (M Units)
Table 110. South America OTC Anti-Infective Products Consumption Value by Country (2018-2023) & (USD Million)
Table 111. South America OTC Anti-Infective Products Consumption Value by Country (2024-2029) & (USD Million)
Table 112. Middle East & Africa OTC Anti-Infective Products Sales Quantity by Type (2018-2023) & (M Units)
Table 113. Middle East & Africa OTC Anti-Infective Products Sales Quantity by Type (2024-2029) & (M Units)
Table 114. Middle East & Africa OTC Anti-Infective Products Sales Quantity by Sales Channel (2018-2023) & (M Units)
Table 115. Middle East & Africa OTC Anti-Infective Products Sales Quantity by Sales Channel (2024-2029) & (M Units)
Table 116. Middle East & Africa OTC Anti-Infective Products Sales Quantity by Region (2018-2023) & (M Units)
Table 117. Middle East & Africa OTC Anti-Infective Products Sales Quantity by Region (2024-2029) & (M Units)
Table 118. Middle East & Africa OTC Anti-Infective Products Consumption Value by Region (2018-2023) & (USD Million)
Table 119. Middle East & Africa OTC Anti-Infective Products Consumption Value by Region (2024-2029) & (USD Million)
Table 120. OTC Anti-Infective Products Raw Material
Table 121. Key Manufacturers of OTC Anti-Infective Products Raw Materials
Table 122. OTC Anti-Infective Products Typical Distributors
Table 123. OTC Anti-Infective Products Typical Customers
List of Figures
Figure 1. OTC Anti-Infective Products Picture
Figure 2. Global OTC Anti-Infective Products Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global OTC Anti-Infective Products Consumption Value Market Share by Type in 2022
Figure 4. Antifungal Examples
Figure 5. Antibacterial Examples
Figure 6. Antiviral Examples
Figure 7. Antiseptics Examples
Figure 8. Others Examples
Figure 9. Global OTC Anti-Infective Products Consumption Value by Sales Channel, (USD Million), 2018 & 2022 & 2029
Figure 10. Global OTC Anti-Infective Products Consumption Value Market Share by Sales Channel in 2022
Figure 11. Hospital Pharmacies Examples
Figure 12. Retail Pharmacies Examples
Figure 13. Online Pharmacies Examples
Figure 14. Global OTC Anti-Infective Products Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 15. Global OTC Anti-Infective Products Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 16. Global OTC Anti-Infective Products Sales Quantity (2018-2029) & (M Units)
Figure 17. Global OTC Anti-Infective Products Average Price (2018-2029) & (US$/Unit)
Figure 18. Global OTC Anti-Infective Products Sales Quantity Market Share by Manufacturer in 2022
Figure 19. Global OTC Anti-Infective Products Consumption Value Market Share by Manufacturer in 2022
Figure 20. Producer Shipments of OTC Anti-Infective Products by Manufacturer Sales Quantity ($MM) and Market Share (%): 2021
Figure 21. Top 3 OTC Anti-Infective Products Manufacturer (Consumption Value) Market Share in 2022
Figure 22. Top 6 OTC Anti-Infective Products Manufacturer (Consumption Value) Market Share in 2022
Figure 23. Global OTC Anti-Infective Products Sales Quantity Market Share by Region (2018-2029)
Figure 24. Global OTC Anti-Infective Products Consumption Value Market Share by Region (2018-2029)
Figure 25. North America OTC Anti-Infective Products Consumption Value (2018-2029) & (USD Million)
Figure 26. Europe OTC Anti-Infective Products Consumption Value (2018-2029) & (USD Million)
Figure 27. Asia-Pacific OTC Anti-Infective Products Consumption Value (2018-2029) & (USD Million)
Figure 28. South America OTC Anti-Infective Products Consumption Value (2018-2029) & (USD Million)
Figure 29. Middle East & Africa OTC Anti-Infective Products Consumption Value (2018-2029) & (USD Million)
Figure 30. Global OTC Anti-Infective Products Sales Quantity Market Share by Type (2018-2029)
Figure 31. Global OTC Anti-Infective Products Consumption Value Market Share by Type (2018-2029)
Figure 32. Global OTC Anti-Infective Products Average Price by Type (2018-2029) & (US$/Unit)
Figure 33. Global OTC Anti-Infective Products Sales Quantity Market Share by Sales Channel (2018-2029)
Figure 34. Global OTC Anti-Infective Products Consumption Value Market Share by Sales Channel (2018-2029)
Figure 35. Global OTC Anti-Infective Products Average Price by Sales Channel (2018-2029) & (US$/Unit)
Figure 36. North America OTC Anti-Infective Products Sales Quantity Market Share by Type (2018-2029)
Figure 37. North America OTC Anti-Infective Products Sales Quantity Market Share by Sales Channel (2018-2029)
Figure 38. North America OTC Anti-Infective Products Sales Quantity Market Share by Country (2018-2029)
Figure 39. North America OTC Anti-Infective Products Consumption Value Market Share by Country (2018-2029)
Figure 40. United States OTC Anti-Infective Products Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 41. Canada OTC Anti-Infective Products Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 42. Mexico OTC Anti-Infective Products Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 43. Europe OTC Anti-Infective Products Sales Quantity Market Share by Type (2018-2029)
Figure 44. Europe OTC Anti-Infective Products Sales Quantity Market Share by Sales Channel (2018-2029)
Figure 45. Europe OTC Anti-Infective Products Sales Quantity Market Share by Country (2018-2029)
Figure 46. Europe OTC Anti-Infective Products Consumption Value Market Share by Country (2018-2029)
Figure 47. Germany OTC Anti-Infective Products Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 48. France OTC Anti-Infective Products Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 49. United Kingdom OTC Anti-Infective Products Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 50. Russia OTC Anti-Infective Products Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 51. Italy OTC Anti-Infective Products Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 52. Asia-Pacific OTC Anti-Infective Products Sales Quantity Market Share by Type (2018-2029)
Figure 53. Asia-Pacific OTC Anti-Infective Products Sales Quantity Market Share by Sales Channel (2018-2029)
Figure 54. Asia-Pacific OTC Anti-Infective Products Sales Quantity Market Share by Region (2018-2029)
Figure 55. Asia-Pacific OTC Anti-Infective Products Consumption Value Market Share by Region (2018-2029)
Figure 56. China OTC Anti-Infective Products Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 57. Japan OTC Anti-Infective Products Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 58. Korea OTC Anti-Infective Products Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 59. India OTC Anti-Infective Products Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 60. Southeast Asia OTC Anti-Infective Products Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 61. Australia OTC Anti-Infective Products Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 62. South America OTC Anti-Infective Products Sales Quantity Market Share by Type (2018-2029)
Figure 63. South America OTC Anti-Infective Products Sales Quantity Market Share by Sales Channel (2018-2029)
Figure 64. South America OTC Anti-Infective Products Sales Quantity Market Share by Country (2018-2029)
Figure 65. South America OTC Anti-Infective Products Consumption Value Market Share by Country (2018-2029)
Figure 66. Brazil OTC Anti-Infective Products Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 67. Argentina OTC Anti-Infective Products Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 68. Middle East & Africa OTC Anti-Infective Products Sales Quantity Market Share by Type (2018-2029)
Figure 69. Middle East & Africa OTC Anti-Infective Products Sales Quantity Market Share by Sales Channel (2018-2029)
Figure 70. Middle East & Africa OTC Anti-Infective Products Sales Quantity Market Share by Region (2018-2029)
Figure 71. Middle East & Africa OTC Anti-Infective Products Consumption Value Market Share by Region (2018-2029)
Figure 72. Turkey OTC Anti-Infective Products Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 73. Egypt OTC Anti-Infective Products Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 74. Saudi Arabia OTC Anti-Infective Products Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 75. South Africa OTC Anti-Infective Products Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 76. OTC Anti-Infective Products Market Drivers
Figure 77. OTC Anti-Infective Products Market Restraints
Figure 78. OTC Anti-Infective Products Market Trends
Figure 79. Porters Five Forces Analysis
Figure 80. Manufacturing Cost Structure Analysis of OTC Anti-Infective Products in 2022
Figure 81. Manufacturing Process Analysis of OTC Anti-Infective Products
Figure 82. OTC Anti-Infective Products Industrial Chain
Figure 83. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 84. Direct Channel Pros & Cons
Figure 85. Indirect Channel Pros & Cons
Figure 86. Methodology
Figure 87. Research Process and Data Source
